相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Synthesis, in vitro Antileishmanial Efficacy and Hit/Lead Identification of Nitrofurantoin-Triazole Hybrids
Nonkululeko H. Zuma et al.
CHEMMEDCHEM (2022)
Mutations in an Aquaglyceroporin as a Proven Marker of Antimony Clinical Resistance in the Parasite Leishmania donovani
Jade-Eva Potvin et al.
CLINICAL INFECTIOUS DISEASES (2021)
Synthesis and in vitro antileishmanial efficacy of novel benzothiadiazine-1,1-dioxide derivatives
Daisy K. Mangwegape et al.
ARCHIV DER PHARMAZIE (2021)
Overcoming multi-resistant leishmania treatment by nanoencapsulation of potent antimicrobials
Simone S. C. Oliveira et al.
JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY (2021)
The global procurement landscape of leishmaniasis medicines
Hye Lynn Choi et al.
PLOS NEGLECTED TROPICAL DISEASES (2021)
Single- and Two-Electron Reduction of Nitroaromatic Compounds by Flavoenzymes: Mechanisms and Implications for Cytotoxicity
Narimantas Cenas et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Monocyclic Nitro-heteroaryl Nitrones with Dual Mechanism of Activation: Synthesis and Antileishmanial Activity
Juliana da Silva Pacheco et al.
ACS MEDICINAL CHEMISTRY LETTERS (2021)
Bio-guided isolation of anti-leishmanial natural products from Diospyros gracilescens L. (Ebenaceae)
Cyrille Armel N. Njanpa et al.
BMC COMPLEMENTARY MEDICINE AND THERAPIES (2021)
Synthesis and in vitro antileishmanial efficacy of benzyl analogues of nifuroxazide
Christina Kannigadu et al.
DRUG DEVELOPMENT RESEARCH (2021)
Design, synthesis, antileishmanial, and antifungal biological evaluation of novel 3,5-disubstituted isoxazole compounds based on 5-nitrofuran scaffolds
Ozildeia S. Trefzger et al.
ARCHIV DER PHARMAZIE (2020)
Single-step synthesis and in vitro anti-mycobacterial activity of novel nitrofurantoin analogues
Nonkululeko H. Zuma et al.
BIOORGANIC CHEMISTRY (2020)
Synthesis and in vitro evaluation of new 5-substituted 6-nitroimidazooxazoles as antikinetoplastid agents
Fanny Mathias et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review
Chuang Zhao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Chemotherapy of leishmaniasis: present challenges
Silvia R. B. Uliana et al.
PARASITOLOGY (2018)
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
Nicholas A. Meanwell
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Marine-Derived Penicillium Species as Producers of Cytotoxic Metabolites
Sen Liu et al.
MARINE DRUGS (2017)
Exploiting Knowledge on Leishmania Drug Resistance to Support the Quest for New Drugs
Aya Hefnawy et al.
TRENDS IN PARASITOLOGY (2017)
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
Antoine Daina et al.
SCIENTIFIC REPORTS (2017)
Hit and lead criteria in drug discovery for infectious diseases of the developing world
Kei Katsuno et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning
Marcel Kaiser et al.
PLOS ONE (2015)
Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids
Kunal Nepali et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Evaluating 5-Nitrofurans as Trypanocidal Agents
Christopher Bot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Importance of Relating Efficacy Measures to Unbound Drug Concentrations for Anti-Infective Agents
Daniel Gonzalez et al.
CLINICAL MICROBIOLOGY REVIEWS (2013)
Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis
Johannes Blum et al.
INTERNATIONAL HEALTH (2012)
Mechanisms of Drug Toxicity and Relevance to Pharmaceutical Development
F. Peter Guengerich
DRUG METABOLISM AND PHARMACOKINETICS (2011)
A Screen against Leishmania Intracellular Amastigotes: Comparison to a Promastigote Screen and Identification of a Host Cell-Specific Hit
Geraldine De Muylder et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Antileishmanial High-Throughput Drug Screening Reveals Drug Candidates with New Scaffolds
Jair L. Siqueira-Neto et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
In Vitro Susceptibilities of Leishmania donovani Promastigote and Amastigote Stages to Antileishmanial Reference Drugs: Practical Relevance of Stage-Specific Differences
Marieke Vermeersch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Hydrolytic stability of hydrazones and oximes
Jeet Kalia et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2008)
Trifluoromethyl ethers - synthesis and properties of an unusual substituent
Frederic R. Leroux et al.
BEILSTEIN JOURNAL OF ORGANIC CHEMISTRY (2008)
Inhibition of ABC transporters abolishes antimony resistance in Leishmania infection
Jayati Mookerjee Basu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Molecular properties that influence the oral bioavailability of drug candidates
DF Veber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Benzyloxybenzaldehyde analogues as novel adenylyl cyclase activators
CY Chang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)